| (Values in U.S. Thousands) | Dec, 2023 | Dec, 2022 | Dec, 2021 | Dec, 2020 | Dec, 2019 |
| Sales | 8,010 | 6,940 | 400 | 1,820 | 7,920 |
| Sales Growth | +15.42% | +1,635.00% | -78.02% | -77.02% | +388.89% |
| Net Income | -5,690 | -21,100 | -39,470 | -20,910 | -23,880 |
| Net Income Growth | +73.03% | +46.54% | -88.76% | +12.44% | -46.95% |
Fresh Tracks Therapeutics Inc (FRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fresh Tracks Therapeutics Inc. is a clinical-stage pharmaceutical company. Its product pipeline includes Cialis(R), Taltz(R), Gemzar(R), Prozac(R), Cymbalta(R), Juvederm(R), Pluvicto(R) and Sofpironium Bromide. Fresh Tracks Therapeutics Inc., formerly known as Brickell Biotech Inc., is based in BOULDER, Colo.
Fiscal Year End Date: 12/31